m+Medelevator.RU
← Поиск публикаций
The FEBS journal · 2026

Constrictions and shear stress are key determinants of amyloidogenic light chain (AL) amyloidosis.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Goto Yuji, Yamaguchi Keiichi, Nakajima Kichitaro, Yumen Ikuko, He Ruiming, Matsuda Hirokazu, Wazawa Tetsuichi, Nagai Takeharu, Tsukada Nobuhiro, Yamamoto Suguru, Buchner Johannes, Ogi Hirotsugu

Аннотация

Amyloid fibrils, crystal-like aggregates of denatured proteins, form upon breakdown of supersaturation and underlie amyloidosis in diseases, such as Alzheimer's, Parkinson's, and amyloidogenic light chain (AL) disease. In AL amyloidosis, fibrils accumulate in the heart, where they are exposed to shear stress. To mimic cardiac amyloidosis, where each heartbeat causes diameter fluctuations in coronary arterioles, we employ a peristaltic pump using the same mechanical principle to induce shear stress, combined with thioflavin T fluorescence microscopy for in situ real-time observation of amyloid formation of an AL protein associated with heart amyloidosis. Our results demonstrate that confined geometries amplify shear stress-dependent amyloid nucleation. Furthermore, using grid-type microchannels to model arteriole networks under shear stress, we observed fluorescent amyloid bursts reflecting dynamic pathways shaped by fibril deposition, local mechanical stress, and channel occlusion. We also observed that mechanical agitation using a micromanipulator, in conjunction with disaggregating agents, was effective for removing amyloid deposits. Collectively, our findings reveal key principles underlying shear stress-dependent amyloid formation and provide a novel framework for understanding amyloid deposition in organs, potentially advancing anti-amyloidosis strategies.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты